The IPO4 Knockout SK-HEP-1 Polyclonal Cells product provides a ready-to-use, CRISPR/Cas9-edited polyclonal population of SK-HEP-1 cells carrying a targeted disruption of the IPO4 gene. This knockout model offers a powerful loss-of-function tool for studying importin-4 (IPO4)-dependent nuclear transport processes in a human hepatic adenocarcinoma background. As a polyclonal pool, the population retains heterogeneous knockout alleles, enabling robust and reproducible assessment of IPO4 function across a diverse cellular context without the clonal bias inherent in single-cell-derived lines.
The host cell line, SK-HEP-1, is a well-characterized human liver adenocarcinoma cell line originally isolated from ascitic fluid. It exhibits an epithelial morphology and is widely employed in hepatocellular carcinoma research due to its reproducible growth characteristics, tumorigenic potential, and relevance to liver cancer biology. This cell line provides a physiologically pertinent platform for investigating how nucleocytoplasmic transport dysregulation contributes to hepatic malignancies.
IPO4 (importin-4) operates as a karyopherin ?? family nuclear transport receptor that orchestrates the cytoplasmic-to-nuclear translocation of specific cargoes through the nuclear pore complex. Its transport cycle is stringently regulated by the small GTPase RAN, with RAN??GTP promoting cargo release within the nucleus. Mechanistically, IPO4 recognizes nuclear localization signal (NLS)-bearing ribosomal proteins??such as RPL23A??and core histones H2A, H2B, H3, and H4, facilitating their nuclear import. This process critically depends on the RAN GTPase cycle and involves key transport cofactors including importin beta and NTF2, which collectively ensure proper cargo delivery for ribosome biogenesis and chromatin assembly.
Disruption of IPO4 in SK-HEP-1 cells holds particular significance for hepatic cancer studies, as aberrant nuclear transport is frequently implicated in oncogenic transformation and viral pathogenesis. By ablating IPO4-mediated import of ribosomal proteins and histones, this knockout model enables researchers to dissect how defective nucleocytoplasmic trafficking impacts ribosome biogenesis, histone supply, and cell cycle progression in liver adenocarcinoma cells. Furthermore, it provides a valuable context for evaluating IPO4??s role in cancer cell proliferation and the potential consequences of its dysfunction on viral life cycles that hijack host nuclear import machinery.
This IPO4 knockout cell population is suited for a wide spectrum of experimental applications. Researchers can employ immunofluorescence microscopy to monitor subcellular mislocalization of cargo proteins, co-immunoprecipitation assays to probe disrupted importin?Ccargo interactions, and western blotting to quantify changes in nuclear versus cytoplasmic distribution of ribosomal proteins and histones. Transcriptional profiling via RNA-seq can reveal downstream gene expression alterations, while cell proliferation and viability assays assess functional consequences of IPO4 loss. For detailed information on culture conditions and experimental guidance, please contact Ascent Research.
